#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Immune thrombocytopenia Hypertriglyceridaemia Neuroendocrine tumour Polycystic liver disease Neonatal asphyxia Craniocerebral injury Ocular myasthenia Anti-myelin-associated glycoprotein antibodies positive Retinitis pigmentosa Hereditary angioedema with C1 esterase inhibitor deficiency Chemical burn Congenital absence of bile ducts Renal disorder B-cell type acute leukaemia Epilepsy with myoclonic-atonic seizures More trials…

    Learn about Rare Diseases

    Undifferentiated sarcoma – Treatment Systemic sclerosis pulmonary – Diagnostics Mucopolysaccharidosis III Medulloblastoma recurrent – Diagnostics Glomerulonephritis membranous – Basic Information Ewing’s sarcoma metastatic – Diagnostics Osteosarcoma recurrent – Life with Disease Wolfram syndrome – Trials in Disease Glycogen storage disease type V – Diagnostics Hereditary ataxia – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Sotorasib Mogamulizumab Lomustine Vemurafenib Berzosertib Zolbetuximab Cilastatin Protrans Nicotine Epcoritamab Xp-Dc+Tl+Klh Deferiprone Omp65 Ranitidine Hydrochloride Pabinafusp Alfa DIMENHYDRINATE Zamtocabtagene Autoleucel Alizapride Fluoroethyltyrosine F-18 Talquetamab More therapies…

    Learn about Your Condition

    Dyslipidaemia Langerhans cell sarcoma Rasmussen encephalitis Plasma cell myeloma refractory Nervous system disorder Biotinidase deficiency Hypertonic bladder Anal fissure Dementia with Lewy bodies Vulvovaginal candidiasis Congenital aplastic anaemia Meniscus operation Cutaneous lupus erythematosus Endometrial cancer recurrent Injection site pain More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Cervix carcinoma

  • Study of Dostarlimab for Patients with High-Risk Locally Advanced Cervical Cancer After Chemo-Radiation

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Cervix carcinoma
    Investigated Drugs:
    • Dostarlimab
    Spain

  • Study of LN-145 (tumor infiltrating lymphocytes) with cyclophosphamide, fludarabine, and aldesleukin in patients with recurrent, metastatic, or persistent cervical cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Cervix carcinoma
    Investigated Drugs:
    • Autologous Tumour-Infiltrating Lymphocytes
    • Aldesleukin
    • Fludarabine Phosphate
    France Germany Italy The Netherlands Spain

  • Study on Tisotumab Vedotin, Bevacizumab, Carboplatin, and Pembrolizumab for Patients with Recurrent or Stage IVB Cervical Cancer

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Cervix carcinoma
    Investigated Drugs:
    • Tisotumab Vedotin
    • Bevacizumab
    • Carboplatin
    Belgium Czechia Ireland Italy The Netherlands Spain

  • Study of JK08, Pembrolizumab, and Lenvatinib for Patients with Advanced or Metastatic Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Thyroid cancer
    • Transitional cell cancer of the renal pelvis and ureter
    • Cervix carcinoma
    Investigated Drugs:
    • Jk08
    • Lenvatinib
    • Pembrolizumab
    Belgium Spain

  • Study of Chemoradiotherapy With or Without Pembrolizumab for Patients With High-Risk, Locally Advanced Cervical Cancer

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Cisplatin
    • Pembrolizumab
    Austria Belgium Czechia France Germany Greece +6

  • Study on the Effectiveness of HPV 9-Valent Vaccine in Women Undergoing LEEP for High-Grade Cervical Lesions or Early Cervical Cancer

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Cervix carcinoma
    Investigated Drugs:
    • Water For Injection
    • Human Papillomavirus Type 11 L1 Protein – Adsorbed – In The Form Of Virus-Like Particles Produced In Yeast Cells (Saccharomyces Cerevisiae Canade 3C-5 (Strain 1895)) By Rdna
    • Human Papillomavirus Type 16 L1 Protein – Adsorbed – In The Form Of Virus-Like Particles Produced In Yeast Cells (Saccharomyces Cerevisiae Canade 3C-5 (Strain 1895)) By Rdna
    Italy
Previous Page
1 … 3 4 5 6
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!